1,168
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Pleckstrin homology-like domain family A, member 3, a miR-19a-3p-regulated gene, suppresses tumor growth in osteosarcoma by downregulating the Akt pathway

, , , , &
Pages 3993-4009 | Received 11 Nov 2021, Accepted 12 Jan 2022, Published online: 03 Feb 2022

References

  • Wu Y, Xie Z, Chen J, et al. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression. Mol Cancer. 2019;18(1):73.
  • Ma J, Gao W, Gao J. sCLU as prognostic biomarker and therapeutic target in osteosarcoma. Bioengineered. 2019;10(1):229–239.
  • Shen S, Yao, T, Xu, Y, et al. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc. Mol Cancer. 2020;19(1):151.
  • Zheng D, Liu W, Xie W, et al. AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcoma. Signal Transduct Target Ther. 2021;6(1):25.
  • Wang X, Qin G, Liang X, et al. Targeting the CK1alpha/CBX4 axis for metastasis in osteosarcoma. Nat Commun. 2020;11(1):1141.
  • Tonella L, Pala V, Ponti R, et al. Prognostic and predictive biomarkers in stage III melanoma: current insights and clinical implications. Int J Mol Sci. 2021;22(9):4561.
  • Fang J, Ge X, Xu W, et al. Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer. J Cell Physiol. 2020;235(4):3438–3446.
  • Leung SW, Chia-Jung C, Tsui-Chin H, et al. An integrated bioinformatics analysis repurposes an antihelminthic drug niclosamide for treating HMGA2-overexpressing human colorectal cancer. Cancers (Basel). 2019;11(10):1482.
  • Huang S, Zhao J, Song J, et al. Interferon alpha-inducible protein 27 (IFI27) is a prognostic marker for pancreatic cancer based on comprehensive bioinformatics analysis. Bioengineered. 2021;12(1):8515–8528.
  • Fan L, Cao X, Lei Y. MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway. Bioengineered. 2021;12(2):12568–12582.
  • Keremu A, Maimaiti X, Aimaiti A, et al. NRSN2 promotes osteosarcoma cell proliferation and growth through PI3K/Akt/MTOR and Wnt/beta-catenin signaling. Am J Cancer Res. 2017;7(3):565–573.
  • Kawase T, Ohki R, Shibata T, et al. PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt. Cell. 2009;136(3):535–550.
  • Ohki R, Saito K, Chen Y, et al. PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors. Proc Natl Acad Sci U S A. 2014;111(23):E2404–13.
  • Ma S, Quan P, Yu C, et al. PHLDA3 exerts an antitumor function in prostate cancer by down-regulating Wnt/beta-catenin pathway via inhibition of Akt. Biochem Biophys Res Commun. 2021;571:66–73.
  • Takikawa M, Ohki R. A vicious partnership between AKT and PHLDA3 to facilitate neuroendocrine tumors. Cancer Sci. 2017;108(6):1101–1108.
  • F RM, AV Valoyes M, G Do Nascimento R, et al. Prognostic and predictive value of Pleckstrin homology-like domain, family A family members in breast cancer. Biomark Med. 2020;14(16):1537–1552.
  • Zhang D, Lin J, Chao Y, et al. Regulation of the adaptation to ER stress by KLF4 facilitates melanoma cell metastasis via upregulating NUCB2 expression. J Exp Clin Cancer Res. 2018;37(1):176.
  • Zhou K, Chen J, Wu J, et al. Profilin 2 promotes proliferation and metastasis of head and neck cancer cells by regulating PI3K/AKT/beta-catenin signaling pathway. Oncol Res. 2019;27(9):1079–1088.
  • Cheng J, Huang Y, Zhang X, et al. TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism. Nat Commun. 2020;11(1):1880.
  • Luo T, Zhou X, Jiang E, et al. Osteosarcoma cell-derived small extracellular vesicles enhance osteoclastogenesis and bone resorption through transferring MicroRNA-19a-3p. Front Oncol. 2021;11:618662.
  • Zhang B, Liu Y, Zhang J. Silencing of miR-19a-3p enhances osteosarcoma cells chemosensitivity by elevating the expression of tumor suppressor PTEN. Oncol Lett. 2019;17(1):414–421.
  • Saito M, Sada A, Fukuyo M, et al. PHLDA3 is an important downstream mediator of p53 in squamous cell carcinogenesis. J Invest Dermatol. 2021. DOI:10.1016/j.jid.2021.09.007.
  • Lee CG, Kang YJ, Kim HS, et al. Phlda3, a urine-detectable protein, causes p53 accumulation in renal tubular cells injured by cisplatin. Cell Biol Toxicol. 2015;31(2):121–130.
  • Lee CG, Kim JG, Kim HJ, et al. Discovery of an integrative network of microRNAs and transcriptomics changes for acute kidney injury. Kidney Int. 2014;86(5):943–953.
  • Qiao M, Wu M, Shi R, et al. PHLDA3 impedes somatic cell reprogramming by activating Akt-GSK3beta pathway. Sci Rep. 2017;7(1):2832.
  • Liu J, Liu X, Hui X, et al. Novel role for pleckstrin homology-like domain family a, member 3 in the regulation of pathological cardiac hypertrophy. J Am Heart Assoc. 2019;8(16):e011830.
  • Liu L, Dai Y, Chen J, et al. Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3beta/Snail signaling. Hepatology. 2014;59(2):531–543.
  • An P, Chen F, Li Z, et al. HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3beta/Snail signals. Oncogene. 2020;39(26):4956–4969.
  • Sun J, Tang Q, Gao Y, et al. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3beta signaling. J Exp Clin Cancer Res. 2020;39(1):104.
  • Zhang S, Wang J, Chen T, et al. alpha-Actinin1 promotes tumorigenesis and epithelial-mesenchymal transition of gastric cancer via the AKT/GSK3beta/beta-Catenin pathway. Bioengineered. 2021;12(1):5688–5704.
  • Zhang Y, Cheng H, Li W, et al. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling. Int J Cancer. 2019;145(4):1068–1082.
  • Liang C, Yu, X, Xiong, N, et al. Pictilisib enhances the antitumor effect of doxorubicin and prevents tumor-mediated bone destruction by blockade of PI3K/AKT pathway. Front Oncol. 2020;10:615146.
  • Chen Y, and Ohki R. p53-PHLDA3-Akt network: the key regulators of neuroendocrine tumorigenesis. Int J Mol Sci. 2020;21(11):4098.
  • Lin J, Liao, S, Li, E, et al. circCYFIP2 acts as a sponge of mir-1205 and affects the expression of its target gene E2F1 to regulate gastric cancer metastasis. Mol Ther Nucleic Acids. 2020;21:121–132.
  • Ren R, Yuan Z, Xu Z. miRNA-144 targeting DNAJC3-AS1 reverses the resistance of the breast cancer cell line Michigan Cancer Foundation-7 to doxorubicin. Bioengineered. 2021;12(2):9885–9892.
  • Sun HX, Yang Z-F, Tang W-G, et al. MicroRNA-19a-3p regulates cell growth through modulation of the PIK3IP1-AKT pathway in hepatocellular carcinoma. J Cancer. 2020;11(9):2476–2484.
  • Qiao F, Gong P, Song Y, et al. Downregulated PITX1 modulated by MiR-19a-3p promotes cell malignancy and predicts a poor prognosis of gastric cancer by affecting transcriptionally activated PDCD5. Cell Physiol Biochem. 2018;46(6):2215–2231.
  • Jiang XM, Yu X-N, Liu -T-T, et al. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma. Biomed Pharmacother. 2018;105:1147–1154.
  • Lee S, Lee, H, Bae, H, et al. Epigenetic silencing of miR-19a-3p by cold atmospheric plasma contributes to proliferation inhibition of the MCF-7 breast cancer cell. Sci Rep. 2016;6(1):30005.